KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cognizant Technology Solutions (CTSH) Current Deferred Revenue (2016 - 2026)

Cognizant Technology Solutions has reported Current Deferred Revenue over the past 18 years, most recently at $580.0 million for Q1 2026.

  • Quarterly Current Deferred Revenue rose 11.75% to $580.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $580.0 million through Mar 2026, up 11.75% year-over-year, with the annual reading at $501.0 million for FY2025, 11.33% up from the prior year.
  • Current Deferred Revenue was $580.0 million for Q1 2026 at Cognizant Technology Solutions, up from $501.0 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $580.0 million in Q1 2026 and troughed at $302.0 million in Q3 2023.
  • The 5-year median for Current Deferred Revenue is $408.0 million (2022), against an average of $424.2 million.
  • Year-over-year, Current Deferred Revenue fell 12.46% in 2023 and then grew 17.55% in 2024.
  • A 5-year view of Current Deferred Revenue shows it stood at $398.0 million in 2022, then fell by 3.27% to $385.0 million in 2023, then increased by 16.88% to $450.0 million in 2024, then grew by 11.33% to $501.0 million in 2025, then rose by 15.77% to $580.0 million in 2026.
  • Per Business Quant, the three most recent readings for CTSH's Current Deferred Revenue are $580.0 million (Q1 2026), $501.0 million (Q4 2025), and $384.0 million (Q3 2025).